Evidence map›Paper›PMID 32662307›Full record

ArticleRenal failure2020

Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study.

Hiroyuki Yoshida, Daijo Inaguma, Eri Koshi-Ito, Soshiro Ogata, Akimitsu Kitagawa, Kazuo Takahashi, Shigehisa Koide, Hiroki Hayashi, Midori Hasegawa, Yukio Yuzawa and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Renal failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hiroyuki YoshidaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Daijo InagumaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID https://orcid.org/0000-0002-3977-5933
Eri Koshi-ItoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-0089-5468
Soshiro OgataFaculty of Nursing, School of Health Sciences, Fujita Health University, Toyoake, Japan.
Akimitsu KitagawaDepartment of Nephrology, Fujita Health University, Bantane Hospital, Nagoya, Japan.
Kazuo TakahashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Shigehisa KoideDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Hiroki HayashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Midori HasegawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Naotake TsuboiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are few studies on the association between serum uric acid (UA) level and mortality in incident dialysis patients. We aimed to clarify whether the serum UA level at dialysis initiation is associated with mortality during maintenance dialysis.

methodsWe enrolled 1486 incident dialysis patients who participated in a previous multicenter prospective cohort study in Japan. We classified the patients into the following five groups according to their serum UA levels at dialysis initiation: G1 with a serum UA level <6 mg/dL; G2, 6.0-8.0 mg/dL; G3, 8.0-10.0 mg/dL; G4, 10.0-12.0 mg/dL; and G5, ≥12.0 mg/dL. We created three models (Model 1: adjusted for age and sex, Model 2: adjusted for Model 1 + 12 variables, and Model 3: stepwise regression adjusted for Model 2 + 13 variables) and performed a multivariate Cox proportional hazard regression analysis to examine the association between the serum UA level and outcomes, including infection-related mortality.

resultsHazard ratios (HRs) were calculated relative to the G2, because the all-cause mortality rate was the lowest in G2. For Models 1 and 2, the all-cause mortality rate was significantly higher in G5 than in G2 (HR: 1.63, 95% confidence interval [CI]: 1.14-2.33 and HR: 1.78, 95% CI: 1.19-2.68, respectively). For Models 1, 2, and 3, the infection-related mortality rate was significantly higher in G5 than in G2 (HR: 2.75, 95% CI: 1.37-5.54, HR: 3.09, 95% CI: 1.45-6.59, HR: 3.37, and 95% CI: 1.24-9.15, respectively).

conclusionsExtreme hyperuricemia (serum UA level ≥12.0 mg/dL) at dialysis initiation is a risk factor for infection-related deaths.

Indexed as

AgedAged, 80 and overFemaleHumansHyperuricemiaJapanKidney Failure, ChronicMaleMiddle AgedMultivariate AnalysisProportional Hazards ModelsProspective StudiesRenal DialysisRisk FactorsUric AcidUric Acidcohortdialysisdialysis initiationHyperuricemiainfectionmortality

Identifiers

PMID32662307
PMCPMC7470168

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.